PROCEPT BioRobotics Corp (PRCT)
88.94
+3.03
(+3.53%)
USD |
NASDAQ |
Nov 15, 16:00
90.59
+1.65
(+1.86%)
After-Hours: 20:00
PROCEPT BioRobotics Research and Development Expense (TTM): 61.73M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.73M |
| June 30, 2024 | 56.68M |
| March 31, 2024 | 50.79M |
| December 31, 2023 | 48.45M |
| September 30, 2023 | 43.63M |
| June 30, 2023 | 39.61M |
| March 31, 2023 | 34.71M |
| Date | Value |
|---|---|
| December 31, 2022 | 28.98M |
| September 30, 2022 | 24.38M |
| June 30, 2022 | 21.71M |
| March 31, 2022 | 19.48M |
| December 31, 2021 | 18.99M |
| September 30, 2021 | 18.46M |
| June 30, 2021 | 17.43M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.43M
Minimum
Jun 2021
61.73M
Maximum
Sep 2024
34.65M
Average
31.84M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| Intuitive Surgical Inc | 1.111B |
| Teleflex Inc | 152.98M |
| Perspective Therapeutics Inc | 28.53M |
| Xtant Medical Holdings Inc | 2.145M |